Semin intervent Radiol 2018; 35(01): 029-034
DOI: 10.1055/s-0038-1636518
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers

Samdeep K. Mouli
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
,
Ramona Gupta
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
,
Neil Sheth
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
,
Andrew C. Gordon
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
,
Robert J. Lewandowski
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois
Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
05 April 2018 (online)

Abstract

Breast cancer is the most common women's malignancy in the United States and is the second leading cause of cancer death. More than half of patients with breast cancer will develop hepatic metastases; this portends a poorer prognosis. In the appropriately selected patient, there does appear to be a role for curative (surgery, ablation) or palliative (intra-arterial treatments) locoregional therapy. Gynecologic malignancies are less common and metastases to the liver are most often seen in the setting of disseminated disease. The role of locoregional therapies in these patients is not well reported. The purpose of this article is to review the outcomes data of locoregional therapies in the treatment of hepatic metastases from breast and gynecologic malignancies.